Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

C&C Group sees H1 earnings in line, net revenue down 3%

(Sharecast News) - Magners cider maker C&C Group said first-half earnings had been in line with expectations, with net revenues expected to be down 3%. Underlying operating profit in the six months to August 31 was expected in the range of €39m-€41m, reflecting the phased rebuilding of C&C's distribution business profitability after a bungled software upgrade at its Matthew Clark and Bibendum businesses hit earnings last year.

Revenues would be it by the disposal of the NAB business in Ireland, lower contract brewing volumes and softer cider volumes in GB.

The Dublin-based company added that it had reached agreement with Budweiser Brewing Group, part of AB InBev, to restructure elements of our trading relationship, with C&C will reassume control and distribution of the group's cider portfolio, including Magners, in Great Britain from January 1, 2025.

On the same date, AB InBev will assume control and distribution of its beer portfolio in the off trade in the Republic of Ireland.

"While current market conditions remain challenging, improving efficiencies, business simplification, winning customers and brand distribution remain our top priorities. We remain confident on achieving our operating profit target for the current financial year and making progress towards the operating profit target of €100m by full-year 2027," C&C said.

It also reaffirms its intention to distribute at least €150m to shareholders over three years while maintaining the group's financial leverage target of approximately 1 times core earnings.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Broker tips: GSK, Central Asia Metals
(Sharecast News) - GSK's $2.2bn payment to settle 93% of outstanding Zantac lawsuits in the US was close to the "best case scenario", according to Jefferies, which said the announcement should remove a significant weight on the share price.
Domino's tops Q3 profit forecasts, but cuts sales guidance
(Sharecast News) - Shares in takeaway pizza chain Domino's rose on Thursday as investors focused on forecast-beating quarterly earnings and shrugged off a reduction to sales growth forecasts for the full year.
Polar Capital assets under management rise in first half
(Sharecast News) - Specialist active asset manager Polar Capital reported an increase in its assets under management for the six months ended 30 September on Thursday.
MaxCyte appoints new chief commercial officer
(Sharecast News) - Cell engineering company MaxCyte announced the appointment of Ali Soleymannezhad as its new chief commercial officer on Thursday, effective from 11 September.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.